Dysphagia following chemoradiation for locally advanced head and neck cancer

Annals of Oncology

Volumn 15, Issue 3, 2004, Pages 383-388

  Nguyen, Nam Phong ^a   Moltz, C C ^b   Frank, C ^b   Vos, P ^c   Smith, H J ^b   Karlsson, U ^c   Dutta, S ^d   Midyett, F A ^b   Barloon, J ^b   Sallah, S ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d Medical Center of Plano   (United States)

^e Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Aspiration; Chemoradiation; Dysphagia; Head and neck cancer

Indexed keywords

ANTIBIOTIC AGENT; BARIUM; CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ARTICLE; ASPIRATION PNEUMONIA; CANCER PATIENT; CANCER RADIOTHERAPY; CELLULITIS; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG FATALITY; DYSPHAGIA; ENTERIC FEEDING; FEMALE; FOLLOW UP; FOOD INTAKE; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; KIDNEY DISEASE; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORBIDITY; MUCOSA INFLAMMATION; NASOPHARYNX CANCER; NEUTROPENIA; OROPHARYNX CANCER; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SAFETY; SWALLOWING; THROMBOCYTOPENIA; TUBE FEEDING; WEIGHT REDUCTION;

EID: 11144357953     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh101     Document Type: Article

References (31)

1. Al-Sarraf M. Treatment of locally advanced head and neck cancer, historical and critical review. Cancer Control 2002; 9: 387-399.
2. Lawrence TS, Blackstock AW, McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 2003; 13: 13-21.
3. Nguyen NP, Sallah S. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers. In Vivo 2000; 14: 35-39.
4. Nguyen NP, Antoine JE, Dutta S et al. Current concept in radiation enteritis and implications for future clinical trials. Cancer 2002; 95: 1151-1163.
5. Smith RV, Kotz T, Beitler JJ, Wadler S. Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea. Arch Otolaryngol Head Neck Surg 2000; 126: 384-389.
6. Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 2002; 94: 1131-1141.
7. Logeman J. Evaluation and Treatment of Swallowing Disorders. San Diego: College-Hill Press 1983.
8. Karnell MP, McCracken E. A data base information storage and reporting system for videofluorographic oropharyngeal motility swallowing evaluation. Am J Speech Language Pathol 1994; 54-60.
9. Tupchong L, Scott CB, Blitzer PH et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991; 20: 21-28.
10. Mose S, Class R, Weber HW et al. Combined radiotherapy and gemcitabine. Evaluation of clinical data based on experimental knowledge. Stralenther Onkol 2002; 178: 59-70.
11. Vokes EE, Stenson K, Rosen FR et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemotherapy: Curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003; 21: 320-326.
12. Newman LA, Vierra F, Schwiezer V et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1998; 124: 589-592.
13. Lazarus CL, Logemann JA, Pauloski BR et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 1996; 106: 1157-1166.
14. Lavertu P, Adelstein DJ, Saxton JP et al. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: An 8-year single institutional experience. Arch Otolaryngol Head Neck Surg 1999; 125: 142-148.
15. Adelstein JJ, Saxton JP, Lavertu P et al. Maximizing local control and organ preservation in stage 4 head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J Clin Oncol 2002; 20: 1405-1410.
16. Machtay M, Rosenthal DI, Hershock D et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced respectable oropharyngeal carcinoma: A University of Pennsylvania phase II trial. J Clin Oncol 2002; 20: 3964-3971.
17. Eisbruch A, Lyden T, Bradford CR et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Rad Oncol Biol Phys 2002: 53: 23-28.
18. Pauloski BR, Rademaker AW, Logemann JA et al. Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 2002; 24: 555-565.
19. Wu CH, Hsiao TY, Ko JY, Hsu MM. Dysphagia after radiation: Endoscopic examination of swallowing in patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000; 109: 320-325.
20. Kotz T, Abraham S, Beitler JJ et al. Pharyngeal dysfunction consequent to an organ sparing protocol. Arch Otol Head Neck Surg 1999; 125: 480-483.
21. Lazarus C, Logemann JA, Song CW et al. Effects of voluntary maneuvers on tongue base function for swallowing. Folia. Phoniatr Logop 2002; 54: 171-176.
22. Pauloski BR, Rademaker AW, Logemann JA, Colangelo LA. Speech and swallowing in irradiated and non-irradiated post surgical oral cancer patients. Otol Head Neck Surg 1998; 118: 616-624.
23. Staton J, Robbins KT, Newman L et al. Factors predicting poor outcome after chemoradiation for advanced laryngeal cancer. Otolaryngo Head Neck Surg 2002; 127: 43-47.
24. Kies MS, Haraf DJ, Rosen F et al. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. J Clin Oncol 2001; 19: 1961-1969.
25. Ackerstaff AH, Tan IB, Rasch CR et al. Quality of life assessment after supradose selective intraarterial cisplatin and concomitant radiation for postoperative stage 4 head and neck cancer. Arch Otolaryngol Head Neck Surg 2002; 128: 1185-1190.
26. Samant S, Kumar P, Wan J et al. Concomitant radiation therapy and targeted cisplatin chemotherapy for the treatment of advanced pyriform sinus carcinoma: Disease control and preservation or organ function. Head Neck 1999; 7: 595-601.
27. Newman LA, Vierra F, Schwiezer V et al. Eating and weight changes following chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngo Head Neck Surg 1998; 124: 589-592.
28. Buntzel J, Glatzel M, Kuttner K et al. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer. Sem Radiat Oncol 2002; 12: 4-13.
29. Stenson KM, McCracken E, List M et al. Swallowing function in patients with head and neck cancer prior to radiotherapy. Arch Otol Laryng Head Neck Surg 2000; 126: 371-377.
30. Adelstein DJ, Adams GL, Wagner H et al. An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous head and neck cancer. J Clin Oncol 2003; 21: 92-98.
31. Brizel DM, Albers ME, Fisher SR et al. Hyperfractionation irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338: 1798-1804.